NEW YORK (GenomeWeb News) – Cancer Genetics today announced it has reached a deal with a second preferred provider organization.

The Rutherford, NJ-based firm has executed an agreement with Three Rivers Provider Network, providing about 15 million of the PPO's members access to Cancer Genetics' testing menu. The deal follows an agreement that Cancer Genetics inked with MultiPlan in May 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.